青松股份(300132.SZ)子公司採購醫用口罩生產設備並取得應急醫療器械生產備案憑證
格隆匯2月5日丨青松股份(300132.SZ)公佈,公司控股子公司諾斯貝爾化粧品股份有限公司(“諾斯貝爾”)積極履行上市公司社會責任,於近日採購醫用口罩生產設備,並向中山市市場監督管理局申請取得《中山市突發公共衞生事件一級響應期間應急醫療器械生產備案憑證》。
此次“新型冠狀病毒感染的肺炎疫情”發生以來,公司積極響應黨和政府號召,貫徹落實國務院及地方政府關於全力加快疫情防控物資生產的部署,公司控股子公司諾斯貝爾為解決醫用口罩生產供應嚴重不足問題,採購了醫用口罩生產設備共5台,每台設備的醫用口罩生產能力為每日4萬隻。目前已有1台設備安裝調試完畢,可正常生產醫用口罩。餘下設備將陸續運抵諾斯貝爾工廠並進行安裝調試。
諾斯貝爾將密切關注疫情防控情況及醫用口罩需求,不排除繼續採購醫用口
罩生產設備,為抗擊疫情提供更多力所能及的幫助。
諾斯貝爾目前已向中山市市場監督管理局申請並取得《中山市突發公共衞生事件一級響應期間應急醫療器械生產備案憑證》,生產範圍為“一次性使用醫用口罩”,備案編號為“粵中市監應急械生產備 2020001號”。
為保障防控“新型冠狀病毒感染的肺炎疫情”工作順利開展,經向中山市南頭鎮人民政府申請,中山市南頭鎮人民政府於 2020年1月31日認定諾斯貝爾屬於“疫情防控必需物資生產企業”,同意諾斯貝爾自2020年1月31日起復工。
在各級政府部門的支持和幫助下,公司控股子公司諾斯貝爾根據疫情防控需要,積極履行社會責任,優先生產疫情急需的醫用口罩、衞生濕巾、消毒液等產品,全力以赴做好疫情防控相關工作,為戰勝疫情貢獻力量。諾斯貝爾全力保障醫用口罩、衞生濕巾、消毒液等疫情防控物資的供應,預計對公司當期經營及投資者利益不構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.